Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-21-000395
Filing Date
2021-04-01
Accepted
2021-04-01 19:29:28
Documents
1
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_7182.html 4  
1 PRIMARY DOCUMENT doc4_7182.xml 4 5853
  Complete submission text file 0001638599-21-000395.txt   7227
Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Haller Julia A (Reporting) CIK: 0001656082 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 21800060

Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations